Pancreas transplantation in type 2 diabetes: expanding the c... : Current Opinion in Organ
Transplantation Pancreas transplantation in type 2 diabetes: expanding the criteria : Current …

The influence of recipient age on outcomes following simultaneous pancreas‐kidney
transplantation (SPKT) in the modern era is uncertain. Methods We retrospectively studied …

Studies have found similar outcomes of Simultaneous Pancreas-Kidney transplantation
(SPKT) in patients with Type 2 (T2D) and Type 1 diabetes (T1D). However, there are scarce …

Following simultaneous pancreas‐kidney transplantation (SPKT), survival outcomes are
reported as equivalent in patients with detectable pretransplant C‐peptide levels (Cp+) and …

Pancreas transplant has evolved significantly in recent years. It has now become a viable
treatment option on type 1 diabetic patients with poorly controlled diabetes on conventional …

Given the increasing frequency of simultaneous pancreas-kidney transplants performed in
recipients with Type II diabetes and CKD, we sought to evaluate possible differences in the …

Islet of Langerhans allotransplantation is a cell therapy option for beta-cell replacement in
the treatment of type 1 diabetes. Islet transplantation has seen significant advances in recent …

Background: Transplant recipients are susceptible to cardiovascular complications, obesity,
and increased insulin resistance after transplant. Here we assess weight gain in diabetic …

In the previous century, vascularized pancreas transplantation (PTx) was performed
predominantly in middle-aged, Caucasian adults with type 1 diabetes mellitus (T1DM) …

Background: Prior to year 2000, the majority of pancreas transplants (PTx) were performed
as simultaneous pancreas-kidney transplants (SPKTs) in Caucasian adults with end stage …